4//SEC Filing
Epstein David M. 4
Accession 0001415889-23-010388
CIK 0001701541other
Filed
Jun 27, 8:00 PM ET
Accepted
Jun 28, 4:02 PM ET
Size
9.5 KB
Accession
0001415889-23-010388
Insider Transaction Report
Form 4
Epstein David M.
DirectorSee Remarks
Transactions
- Sale
Common Stock
2023-06-27$6.70/sh−25,000$167,500→ 671,423 total
Holdings
- 23,090(indirect: See footnote)
Common Stock
- 104,449(indirect: See footnote)
Common Stock
- 16,579(indirect: See footnote)
Common Stock
- 16,579(indirect: See footnote)
Common Stock
- 104,449(indirect: See footnote)
Common Stock
Footnotes (6)
- [F1]Shares sold pursuant to a pre-established 10b5-1 trading plan effective as of December 29, 2022.
- [F2]Shares held by wife.
- [F3]Shares held by David M. Epstein 2019 Trust For Elle. David M. Epstein is the trustee of the David M. Epstein 2019 Trust for Elle and may be deemed to beneficially own these securities.
- [F4]Shares held by David M. Epstein 2019 Trust For Zoe. David M. Epstein is the trustee of the David M. Epstein 2019 Trust for Zoe and may be deemed to beneficially own these securities.
- [F5]Shares held by David M. Epstein 2019 Trust For Robert. David M. Epstein is the trustee of the David M. Epstein 2019 Trust for Robert and may be deemed to beneficially own these securities.
- [F6]Shares held by David M. Epstein 2019 Trust For Shelley. David M. Epstein is the trustee of the David M. Epstein 2019 Trust for Shelley and may be deemed to beneficially own these securities.
Documents
Issuer
Black Diamond Therapeutics, Inc.
CIK 0001701541
Entity typeother
Related Parties
1- filerCIK 0001488668
Filing Metadata
- Form type
- 4
- Filed
- Jun 27, 8:00 PM ET
- Accepted
- Jun 28, 4:02 PM ET
- Size
- 9.5 KB